AU1743900A - Benzylmaltosides as inhibitors of smooth muscle cell proliferation - Google Patents

Benzylmaltosides as inhibitors of smooth muscle cell proliferation Download PDF

Info

Publication number
AU1743900A
AU1743900A AU17439/00A AU1743900A AU1743900A AU 1743900 A AU1743900 A AU 1743900A AU 17439/00 A AU17439/00 A AU 17439/00A AU 1743900 A AU1743900 A AU 1743900A AU 1743900 A AU1743900 A AU 1743900A
Authority
AU
Australia
Prior art keywords
carbon atoms
hydrogen
alkyl
perfluoroalkyl
halogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU17439/00A
Other languages
English (en)
Inventor
Paul Jeffrey Dollings
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wyeth LLC
Original Assignee
American Home Products Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Home Products Corp filed Critical American Home Products Corp
Publication of AU1743900A publication Critical patent/AU1743900A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/18—Acyclic radicals, substituted by carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pulmonology (AREA)
  • Molecular Biology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
AU17439/00A 1998-11-24 1999-11-23 Benzylmaltosides as inhibitors of smooth muscle cell proliferation Abandoned AU1743900A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US19843498A 1998-11-24 1998-11-24
US09198434 1998-11-24
PCT/US1999/027824 WO2000031100A2 (fr) 1998-11-24 1999-11-23 Benzylmaltosides utilises comme inhibiteurs de la proliferation cellulaire des muscles lisses

Publications (1)

Publication Number Publication Date
AU1743900A true AU1743900A (en) 2000-06-13

Family

ID=22733369

Family Applications (1)

Application Number Title Priority Date Filing Date
AU17439/00A Abandoned AU1743900A (en) 1998-11-24 1999-11-23 Benzylmaltosides as inhibitors of smooth muscle cell proliferation

Country Status (7)

Country Link
EP (1) EP1133512A2 (fr)
JP (1) JP2002530424A (fr)
CN (1) CN1333784A (fr)
AU (1) AU1743900A (fr)
BR (1) BR9915571A (fr)
CA (1) CA2350753A1 (fr)
WO (1) WO2000031100A2 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1133510A2 (fr) * 1998-11-24 2001-09-19 American Home Products Corporation Benzylmaltosides acyles, inhibiteurs de proliferation des cellules des muscles lisses
CN105367614B (zh) * 2015-11-24 2019-02-22 中国人民解放军第二军医大学 含有葡萄糖类脂肪酸衍生物的制备方法及其在医药领域的应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL115745A (en) * 1994-11-07 2000-11-21 American Home Prod Acylated benzylglycosides and pharmaceutical compositions containing them
CN1348460A (zh) * 1998-11-24 2002-05-08 美国家用产品公司 作为平滑肌细胞增殖抑制剂的缩醛苄基麦芽糖苷类

Also Published As

Publication number Publication date
CN1333784A (zh) 2002-01-30
WO2000031100A2 (fr) 2000-06-02
BR9915571A (pt) 2001-08-14
WO2000031100A3 (fr) 2000-11-23
CA2350753A1 (fr) 2000-06-02
EP1133512A2 (fr) 2001-09-19
JP2002530424A (ja) 2002-09-17

Similar Documents

Publication Publication Date Title
US6187755B1 (en) Benzylmaltosides as inhibitors of smooth muscle cell proliferation
AU1743900A (en) Benzylmaltosides as inhibitors of smooth muscle cell proliferation
US6339064B1 (en) Benzylglycosylamides as inhibitors of smooth muscle cell proliferation
US6451767B1 (en) Benzylmaltotriosides as inhibitors of smooth muscle cell proliferation
US6291434B1 (en) Benzylmaltotriosides as inhibitors of smooth muscle cell proliferation
CA2350755A1 (fr) Benzylglycosylamides utilises comme inhibiteurs de la proliferation cellulaire des muscles lisses
US6340670B1 (en) Acetal benzylmaltosides as inhibitors of smooth muscle cell proliferation
US6362170B1 (en) Benzylglycosylamides as inhibitors of smooth muscle cell proliferation
US6258784B1 (en) Acetal benzylmaltosides as inhibitors of smooth muscle cell proliferation
AU1743800A (en) Acetal benzylmaltosides as inhibitors of smooth muscle cell proliferation
AU3791200A (en) Acylated benzylmaltosides as inhibitors of smooth muscle cell proliferation
US7132402B2 (en) Acylated benzylmaltosides as inhibitors of smooth muscle cell proliferation
AU1919800A (en) Benzylmaltotriosides as inhibitors of smooth muscle cell proliferation
MXPA01005178A (en) Benzylmaltosides as inhibitors of smooth muscle cell proliferation
AU1743700A (en) Benzylglycosylamides as inhibitors of smooth muscle cell proliferation
US20040092457A1 (en) Benzyllactobionamides as inhibitors of smooth muscle cell proliferation
CA2350066A1 (fr) Benzylmaltosides acetal utilises comme inhibiteurs de la proliferation cellulaire des muscles lisses
CA2351061A1 (fr) Benzyllactobionamides inhibiteurs de la proliferation des cellules des muscles lisses
MXPA01005173A (en) Acylated benzylmaltosides as inhibitors of smooth muscle cell proliferation
MXPA01005171A (es) Bencilglicosilamidas como inhibidores de la proliferacion de celulas de musculoliso
MXPA01005174A (en) Acetal benzylmaltosides as inhibitors of smooth muscle cell proliferation
MXPA01005179A (en) Benzylglycosylamides as inhibitors of smooth muscle cell proliferation
MXPA01005172A (en) Benzylmaltotriosides as inhibitors of smooth muscle cell proliferation

Legal Events

Date Code Title Description
MK1 Application lapsed section 142(2)(a) - no request for examination in relevant period